Summaries by Inventor Namen, Shelby

Novel Cell Therapy Platform for Cancer using Engineered cDC1 Dendritic Cells
DeSelm, Carl ; Namen, Shelby ; Pandey, Gaurav
T-020903

— Published date: 5/30/2026 Value Proposition: CAR-engineered cDC1 cells (syngeneic or allogeneic) that stably express a proprietary, modular chimeric antigen receptor and demonstrate strong in vivo efficacy against solid tumors, including immunologically ‘cold’ tumors. Technology Descr…